0.2715EUR-1.99%Mkt Cap: 154.04M $P/E: —Today
Sensorion SA, a biotechnology company, engages in the development of novel therapies to restore, treat, and prevent hearing loss disorders in France. The company develops SENS-501, a dual AAV vector gene therapy developm…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap154.04M $
Enterprise Value105.29M $
Revenue (TTM)6.32M $
Gross Profit6.32M $
Net Income (TTM)-31.99M $
Revenue/Share0.0207 USD
Last Price0.2715 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees63
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0012596468
Valuation
P/E (Trailing)—
P/E (Forward)-6.18
PEG—
EV/EBITDA-3.25
EV/Revenue16.66
P/S24.64
P/B1.88
EPS (TTM)-0.10
EPS (Forward)-0.04
52W Range
0.22208% of range0.8080
52W High0.8080 EUR
52W Low0.2220 EUR
Profitability
Gross Margin100.00%
Oper. Margin-399.80%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-66.16%
ROA-50.84%
Growth
Revenue Growth5.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-29.65M $
CapEx (TTM)821.74K $
FCF Margin-298.79%
FCF Yield-12.26%
Net Debt-50.24M $
Net Debt/EBITDA1.55
Balance Sheet
Debt/Equity0.03
Current Ratio4.59
Quick Ratio4.53
Book Value/Sh0.1480 EUR
Cash/Share0.0920 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateSep 15, 2026
Analyst Consensus
Rating—
Target (Mean)1.137 EUR
Upside (mean)+319.0%
Target Range0.7000 EUR – 1.750 EUR
€0.7000+319.0% to mean€1.750
# Analysts4
Ownership
Shares Out.515.33M
Float300.41M
Insiders34.76%
Institutions35.52%
Technical
SMA 500.2660 (+2.1%)
SMA 2000.3449 (-21.3%)
Beta0.42
S&P 52W Chg18.16%
Avg Vol (30d)889.20K
Avg Vol (10d)793.78K
Technical Indicators
RSI (14)47.2
MACD0.0027
MACD Signal0.0030
MACD Hist.-0.0003
BB Upper0.3054 EUR
BB Middle0.2853 EUR
BB Lower0.2651 EUR
BB Width14.10%
ATR (14)0.0144 EUR
Vol Ratio (20d)0.64x